Xlife Sciences AG (XLS) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.003x

Based on the latest financial reports, Xlife Sciences AG (XLS) has a cash flow conversion efficiency ratio of -0.003x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-803.62K ≈ $-1.02 Million USD) by net assets (CHF303.42 Million ≈ $383.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see XLS company net worth for the company's overall valuation and market capitalisation.

Xlife Sciences AG - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Xlife Sciences AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xlife Sciences AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xlife Sciences AG ranked by their cash flow conversion efficiency. Explore Xlife Sciences AG (XLS) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Genohco Inc. KQ:361390	-0.137x
Richmond International Travel & Tours Co Ltd TWO:2743	0.164x
Suprema HQ Inc KQ:094840	0.015x
The Intergroup Corporation NASDAQ:INTG	-0.026x
JHM Consolidation Bhd KLSE:0127	-0.009x
Klevo Rewards Limited AU:KLV	N/A
Unitech Electronics Co. Ltd. TW:3652	-0.005x
Quantum Graphite Ltd AU:QGL	-0.115x

Annual Cash Flow Conversion Efficiency for Xlife Sciences AG (2019–2025)

The table below shows the annual cash flow conversion efficiency of Xlife Sciences AG from 2019 to 2025. View Xlife Sciences AG (XLS) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF372.36 Million ≈ $470.76 Million	CHF-903.00K ≈ $-1.14 Million	-0.002x	-75.63%
2024-12-31	CHF305.26 Million ≈ $385.93 Million	CHF-421.51K ≈ $-532.90K	-0.001x	-315.57%
2023-12-31	CHF268.17 Million ≈ $339.04 Million	CHF171.78K ≈ $217.18K	0.001x	+103.27%
2022-12-31	CHF235.23 Million ≈ $297.40 Million	CHF-4.61 Million ≈ $-5.83 Million	-0.020x	+4.32%
2021-12-31	CHF211.23 Million ≈ $267.06 Million	CHF-4.32 Million ≈ $-5.47 Million	-0.020x	-563.59%
2020-12-31	CHF130.17 Million ≈ $164.57 Million	CHF-401.55K ≈ $-507.67K	-0.003x	+24.57%
2019-12-31	CHF97.38 Million ≈ $123.11 Million	CHF-398.24K ≈ $-503.48K	-0.004x	--

About Xlife Sciences AG

SW:XLS Switzerland Biotechnology

Market Cap

$93.70 Million

CHF74.11 Million CHF

Market Cap Rank

#20177 Global

#194 in Switzerland

Share Price

CHF12.85

Change (1 day)

+2.80%

52-Week Range

CHF12.50 - CHF26.00

All Time High

CHF52.00